|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for Loan Losses | |||||
| Intangible amortization | |||||
| Amortization of subordinated debt issuance costs | |||||
| Net amortization of securities premiums and discounts | |||||
| Deferred income taxes | |||||
| Earnings from investment in bank owned life insurance | |||||
| Proceeds from sale of mortgage loans held for sale | |||||
| Origination of mortgage loans held for sale | |||||
| Gain on sale of mortgage loans held for sale | |||||
| Gain on sale of loans transferred from held for investment to held for sale | |||||
| Net realized loss (gain) on sale of OREO | |||||
| Impairment on OREO | |||||
| Stock-based compensation expense | |||||
| Net realized gain on sale of securities available for sale | |||||
| Net realized gain on sale of securities held to maturity | |||||
| Death benefit on bank owned life insurance | |||||
| Proceeds from sale of SBA loans held for sale | |||||
| Origination of SBA loans held for sale | |||||
| Gain on sale of SBA loans held for sale | |||||
| Gain on sale of premises and equipment | |||||
| Unrealized loss on equity securities | |||||
| Decrease (increase) in assets: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Increase (decrease) in liabilities: | |||||
| Accrued interest payable | |||||
| Other liabilities | |||||
| Net Cash Provided by Operating Activities | |||||
| Net Cash Provided by Operating Activities | |||||
| Cash Flows from Investing Activities | |||||
| Purchase of securities available for sale | |||||
| Purchase of securities held to maturity | |||||
| Proceeds from repayments, calls and maturities of securities available for sale | |||||
| Proceeds from repayments, calls and maturities of securities held to maturity | |||||
| Proceeds from sales of securities available for sale | |||||
| Proceeds from sales of securities held to maturity | |||||
| Proceeds from sale of loans transferred from held for investment to held for sale | |||||
| Net increase in loans | |||||
| Purchase of premises and equipment | |||||
| Proceeds from sale of premises and equipment | |||||
| Purchase of restricted investments, net | |||||
| Proceeds from the sale of OREO | |||||
| Purchase of bank owned life insurance | |||||
| Proceeds from death benefit on bank owned life insurance | |||||
| Net Cash Used in Investing Activities | |||||
| Cash Flows from Financing Activities | |||||
| Net increase in deposits | |||||
| Net (decrease) increase in securities sold under agreements to repurchase | |||||
| Redemption of preferred stock, Series C | |||||
| Proceeds from FHLB and other borrowings | |||||
| Repayment of FHLB and other borrowings | |||||
| Cash dividends paid - preferred stock | |||||
| Cash dividends paid - common stock | |||||
| Proceeds from employee stock purchase plan | |||||
| Proceeds from subordinated debt placement, net of issuance costs of $176,000 | |||||
| Proceeds from exercise of stock options | |||||
| Common stock repurchased | |||||
| Tax benefit related to stock compensation | |||||
| Net Cash Provided by Financing Activities | |||||
| Net (Decrease) Increase in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents – Beginning | |||||
| Cash and Cash Equivalents – Ending | |||||
| Supplementary cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplementary schedule of non-cash activities: | |||||
| Transfer of loans held for investment to loans held for sale | |||||
| OREO acquired in settlement of loans | |||||
Loading...